St. Anna Kinderkrebsforschung
Quick facts
Marketed products
- Grafalon · Other
Phase 3 pipeline
- Fludarabine, OKT3, Treosulfan, Thiotepa · Oncology / Hematology
This is a multi-drug conditioning regimen combining purine analog, T-cell depleting monoclonal antibody, and alkylating agents to suppress the immune system and ablate bone marrow prior to hematopoietic stem cell transplantation. - VP16, ATG · Oncology
VP16 is an alkylating agent that works by cross-linking DNA, thereby inhibiting DNA replication and transcription.
Phase 2 pipeline
- ATG Thymoglobulin · Oncology
T-cell depleting agent
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: